Human CD39 / ENTPD1 (Q96A, N99A, E143A, R147E) Protein
CD39 is also known as Ectonucleoside triphosphate diphosphohydrolase 1, ENTPD1, NTPDase 1, Ecto-ATPDase 1, in the nervous system, could hydrolyze ATP and other nucleotides to regulate purinergic neurotransmission. Could also be implicated in the prevention of platelet aggregation by hydrolyzing platelet-activating ADP to AMP. Hydrolyzes ATP and ADP equally well. NTPDase-1 was originally described as CD39, a B lymphocyte cell surface marker, but it is also present on the surface of natural killer cells, T cells, and some endothelial cells.Regulatory T cells (Tregs) mediate immunosuppression through multiple, non-redundant, cell-contact dependent and independent mechanisms, a growing body of evidence suggests an important role for the CD39-CD73-adenosine pathway. CD39 ectonucleotidase is the rate-limiting enzyme of a cascade leading to the generation of suppressive adenosine that alters CD4 and CD8 T cell and natural killer cell antitumor activities.
Product Specifications
Product Name Alternative
CD39, ENTPD1, NTPDase 1, Entpd1, Ecto-ATPDase 1, Ecto-ATPase 1
UniProt
P49961
Expression Region
Thr 38 - Val 478
Reactivity
Human
Conjugation
Unconjugated
Tag
C-10xHis
Source
Field of Research
Neuroscience; Immunology & Inflammation
Endotoxin
1.0 EU per μg
Purity
95%
Form
Liquid
Molecular Weight
52.1 kDa
Storage Conditions
-70°C
Notes
For research use only.
Applications Notes
NCBI Accession Number
R147, E143, N99, Q96, P49961
Preservative
20 mM Tris,150 mM NaCl, pH8.0
Available Sizes
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog